Consistently sleeping less than five hours a night might raise the risk of developing depressive symptoms, according to a new genetic study led by UCL (University College London) researchers.
Eisai eyes long game for Leqembi amid ‘dramatically’ increasing patient use
Full US approval of Biogen and Eisai’s Alzheimer’s drug Leqembi — and as a result, broad Medicare coverage — has led to a surge in
November 8, 2023